NSEOutcome of Board Meeting3d ago · 6 Nov 2026, 04:45 pm

Outcome of Board Meeting

Alembic Limited · ALEMBICLTD

✦ AI SummaryResults

Alembic Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, with the Board of Directors approving the results. The company's revenue from operations was Rs 3,025 lakhs for the quarter and Rs 7,899 lakhs for the half year, with a net profit after tax of Rs 6,757 lakhs for the quarter and Rs 8,326 lakhs for the half year.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alembic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Attachments (1)

📄

ALEMBICLTD_06112026164308_AL_BM_Outcome_06112026.pdf

pdf

Download →
View document text
Date: 5th November, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing Department, BSE Limited National Stock Exchange of India Limited 1st Floor, Phiroze Jeejeebhoy Towers, "Exchange Plaza" Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 506235 NSE Symbol: ALEMBICL TD Dear Sir, Sub: Outcome of Board Meeting With reference to the captioned subject, the exchanges are hereby informed that the Board of Directors of Alembic Limited at its meeting held today has inter alia approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026: We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and half year ended 3Qth September, 2026. b) Standalone Unaudited Financial Results for the quarter and half year ended 30th September, 2026. c) Limited Review Reports by Statutory Auditors on the Consolidated and Standalone Unaudited Financial Results. The time of commencement of the Board Meeting was 4:00 p.m. and the time of conclusion was 4:30 p.m. We request you to kindly take the same on record. Thanking you, Yours faithfully, Encl.: A/a ALEMBIC LIMITED REGO. OFFICE : ALEMBIC ROAD, VADODARA • 390 003. • TEL : (0265) 6637000 website: www.alembiclimited.com •E-mail: alembic.investors@alembic.co.in • CIN: L26100GJ1907PLC000033 ALEMBIC LIMITED CIN:L26100GJ1907PLC000033 Regd.Office: Alembic Road, Vadodara 390 003 Ph:0265 6637000 www.alembicllmited.com Emall:alemblc.lnvestors@alembic.co.ln Statement of Consolidated Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026 Rs in Lakhs Quarter Ended Half Year Ended Year Ended Sr. 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 No Particulars (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Revenue from Operations 3,025 4,874 5,586 7,899 10,561 23,999 2 Other Income 7,155 596 6,492 7,752 6,851 7,297 3 Total Income 10,180 5,471 12,078 15,650 17,412 31,296 4 Expenses Cost of Materials Consumed 293 493 253 786 598 1,388 Cost of Construction 391 862 1,291 1,253 2,301 6,002 Changes in Inventories of Finished Goods and WIP (218) (51) 40 -269 215 255 Employee Benefit Expenses 1,132 1,046 755 2,178 1,538 3,744 Finance Costs 52 60 56 112 116 228 Depreciation and amortisation expense 356 348 282 704 561 1,239 Other Expenses 898 979 923 1,878 1,628 3,564 Total Expenses 2,904 3,737 3,600 6,641 6,956 16,420 5 Profit Before Tax (3-4) 7,276 1,734 8,478 9,009 10,457 14,876 6 Tax Expenses Current Tax 825 193 1,105 1,018 1,307 2,263 Deferred Tax (306) (29) (233) (335) (236) (10) Short/ (Excess) Provision of earlier years - - - - - 30 7 Net Profit after tax for the Period 6,757 1,570 7,606 8,326 9,386 12,593 8 Share of Associate's Profit/(Loss) 9,530 4,919 5,243 14,449 9,627 19,145 9 Net Profit/(Loss) after tax and Share of Associate's Profit/(Loss) 16,287 6,489 12,849 22,774 19,013 31,738 10 Other Comprehensive Income A (i) Items that will not be reclassified to Profit or (Loss) 7,697 7,048 14,334 14,745 14,816 (10,562) (ii) Income tax relating to items that will not be reclassified to Profit or (Loss) (804) (752) (2,040) (1,557) (2,108) 925 B (i) Items that will be reclassified to Profit or (Loss) (119) 90 302 (30) 334 882 (ii) Income tax relating to items that will be reclassified to Profit or Loss 33 (14) - 19 - - 11 Total Comprehensive lncome/(Loss) for the Period 23,092 12,860 25,446 35,951 32,054 22,983 12 Paid up Equity Share Capital (Face Value of Rs 2/- per share) 5,135.64 5,135.64 5,135.64 5,135.64 5,135.64 5,135.64 13 Other Equity (excluding Revaluation Reserve) 2,24,927 14 Earnings per equity share (FV Rs. 2/- per share) 6.34 2.53 5.00 8.87 7.40 12.36 Basic & Diluted (In Rs.) Alembic limited Segment wise Consolidated Revenue and Results Rs In Lakhs Quarter Ended Half Vear Ended Vear Ended Sr. 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 No Particulars (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Segment Revenue Revenue from Operations a. Active Pharmaceutical Ingredients Business 679 1,171 1,030 1,851 2,326 4,659 b. Real Estate Business 2,345 3,703 4,556 6,048 8,235 19,340 Total Income from Operations (Net) 3,025 4,874 5,586 7,899 10,561 23,999 2 Segment Results (Profit(+)/ Loss(·) before Taxes and Interest from each segment) a. Active Pharmaceutical Ingredients Business (17) 166 195 149 468 565 b. Real Estate Business 467 1,398 2,041 1,864 3,635 8,117 Total 450 1,564 2,236 2,013 4,103 8,682 Unallocable Income and Expenditure (i) Interest Expense (52) (60) (56) {112) (116) (228) (ii) Dividend Income and Gain/(Loss) on Fair Value Change of Financial Asset 6,828 220 6,100 7,047 6,270 6,167 (iii) Other Income/ (Expense) 50 11 199 61 199 255 Total Profit Before Tax 7,276 1,734 8,478 9,009 10,457 14,876 3 Segment Assets a. Active Pharmaceutical Ingredients Business 18,569 18,228 18,430 18,569 18,430 18,081 b. Real Estate Business 53,541 52,873 48,698 53,541 48,698 51,578 c. Unallocated 2,10,528 2,00,856 2,05,560 2,10,528 2,05,560 1,89,291 Total 2,82,638 2,71,957 2,72,689 2,82;638 2,72,689 2,58,951 4 Segment llabllltles a. Active Pharmaceutical Ingredients Business 3,827 3,577 3,255 3,827 3,255 3,480 b. Real Estate Business 7,663 7,765 10,376 7,663 10,376 8,148 c. Unallocated 3,582 3,247 5,478 3,582 5,478 2,814 Total 15,072 14,588 19,108 15,072 19,108 14,442 Notes: 1 The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. 2 The previous quarter's/ year's figures have been regrouped/ rearranged wherever necessary to make it comparable with the current quarter/ year. For Alembic Limited Place : Vadodara Chlrayu Amin Date : 6th November, 2026 Chairman Alembic Limited Statement of Consolidated Assets and Liabilities Rs In Lakhs As at 30th As at 31st Particulars September, 2026 March, 2026 (Unaudited) (Audited) ASSETS Non-Current Assets (a) Property, Plant and Equipments 16,935 16,995 (bl Capital Work-in-Progress 151 150 (c) Investment Property 30,310 30,171 (d) Goodwill 5 5 (e) Financial Assets (i) Investments 32,447 17,310 (ii) Investments accounted using Equity Method 1,78,080 1,70,443 (iii) Others 527 652 (f) Other Non-Current Assets 3,500 3,500 2,61,956 2,39,227 Current Assets (a) Inventories 5,284 5,224 (b) Financial Assets (i) Investments 11,804 9,662 (ii) Trade Receivables 1,547 3,190 (iii) Cash and Cash Equivalents 175 141 (iv) Bank Balances other than Cash and Cash Equivalents 235 187 (v) Others 313 353 (c) Other Current Assets 1,323 966 20,681 19,724 TOTAL - ASSETS 2,82,638 2,58,951 EQUITY AND LIABILITIES Equity (a) Equity Share Capital 5,136 5,136 (b) Other Equity 2,62,430 2,39,373 2,67,565 2,44,509 Liabilities Non-Current Liabilities (a) Financial Liabilities (i) Borrowings - 661 (ii) Other Financial Liabilities 1,302 1,350 (bl Provisions 550 372 (c) Deferred Tax Liability (Net) 3,174 1,929 5,025 4,312 Current Llabllltles (a) Financial Liabilities (i) Borrowings - 403 (ii) Trade Payables a) total outstanding dues of Micro and Small Enterprises 558 687 b) total outstanding dues of Others 1,584 1,698 (iii) Other Financial Liabilities 1,454 1,168 (b) Other Current liabilities 3,817 3,010 (c) Provisions 2,226 2,280 (d) Current Tax Liabilities (Net) 409 885 10,047 10,130 TOTAL - EQUITY AND LIABILITIES 2,82,638 2,58,951 For Alembic Limited Place : Vadodara Date : 6th November, 2026 Alembic Limited Consolidated Statement of Cash Flow for Half Year ended 30th September,2026 Rs In lakhs For the Half Year For the Half Year Ended on 30th Ended on 30th Particulars September, 2026 September, 2025 (Unaudited) (Unaudited) A CASH FLOW FROM OPERATING ACTIVITIES: Net Profit before tax 9,009 10,457 Add: Depreciation 704 561 Interest charged 112 116 (Gain)/ Loss on sale of Property, Plant and Equipments (5) Other Non cash items (317) (86) Less: Interest Income (290) (75 [Showing first 8,000 characters — download PDF for full document]